Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels. [electronic resource]
Producer: 19970408Description: 113-22 p. digitalISSN:- 0021-9150
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Apolipoproteins -- blood
- Cholesterol, HDL -- blood
- Cholesterol, VLDL -- blood
- Delayed-Action Preparations
- Double-Blind Method
- Female
- Follow-Up Studies
- Gemfibrozil -- administration & dosage
- Humans
- Hypercholesterolemia -- blood
- Hypolipidemic Agents -- administration & dosage
- Lipoproteins -- blood
- Male
- Middle Aged
- Prospective Studies
- Triglycerides -- blood
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.